Scholars@Duke publication: Use of abciximab (ReoPro(R)) is not associated with an increase in the risk of stroke: Overview of three randomized trials

Use of abciximab (ReoPro(R)) is not associated with an increase in the risk of stroke: Overview of three randomized trials

Publication , Journal Article

Deckers, J; Califf, RM; Topol, EJ; Lincoff, AM; Tcheng, JE; Simoons, ML

Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

February 1, 1997

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

0735-1097

February 1, 1997

97489 / 97489

ELSEVIER SCIENCE INC

APA

Chicago

ICMJE

MLA

NLM

Deckers, J., Califf, R. M., Topol, E. J., Lincoff, A. M., Tcheng, J. E., & Simoons, M. L. (1997). Use of abciximab (ReoPro(R)) is not associated with an increase in the risk of stroke: Overview of three randomized trials. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 29(2), 97489–97489.

Deckers, J., R. M. Califf, E. J. Topol, A. M. Lincoff, J. E. Tcheng, and M. L. Simoons. “Use of abciximab (ReoPro(R)) is not associated with an increase in the risk of stroke: Overview of three randomized trials.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 29, no. 2 (February 1, 1997): 97489–97489.

Deckers J, Califf RM, Topol EJ, Lincoff AM, Tcheng JE, Simoons ML. Use of abciximab (ReoPro(R)) is not associated with an increase in the risk of stroke: Overview of three randomized trials. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1997 Feb 1;29(2):97489–97489.

Deckers, J., et al. “Use of abciximab (ReoPro(R)) is not associated with an increase in the risk of stroke: Overview of three randomized trials.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 29, no. 2, ELSEVIER SCIENCE INC, Feb. 1997, pp. 97489–97489.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

0735-1097

February 1, 1997

97489 / 97489

ELSEVIER SCIENCE INC